Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?
Tonneijck L, Muskiet MH, Smits MM, van Raalte DH, Diamant M. Tonneijck L, et al. Among authors: van raalte dh. Lancet Diabetes Endocrinol. 2014 Sep;2(9):684-5. doi: 10.1016/S2213-8587(14)70167-6. Epub 2014 Aug 10. Lancet Diabetes Endocrinol. 2014. PMID: 25127482 No abstract available.
Incretin-based drugs and renoprotection-is hyperfiltration key?
Tonneijck L, Smits MM, van Raalte DH, Muskiet MH. Tonneijck L, et al. Among authors: van raalte dh. Kidney Int. 2015 Mar;87(3):660-1. doi: 10.1038/ki.2014.398. Kidney Int. 2015. PMID: 25723636 Free article. No abstract available.
234 results